Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as a list of publications related to a clinical study. Notably, the MedlinePlus related topics have been expanded to include drug safety and counterfeit drugs.
    Difference
    21%
    Check dated 2025-08-30T15:39:04.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The webpage has been updated with new dates for future events, specifically adding estimated last update dates in August 2025, while removing outdated dates from January 2022.
    Difference
    1.0%
    Check dated 2025-08-23T14:14:44.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:34:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T08:01:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T04:09:56.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-26T00:42:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.